2026 NPPES data Reproductive Endocrinology Physician NPI 1912160680 MD
Verify on CMS →

WINIFRED MAK, MD

Reproductive Endocrinology Physician in PHILADELPHIA, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
24
Medicare Part D claims · Reproductive Endocrinology Physician avg: 104
Generic prescribing
54%
generic claims · 46% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
71.5366/100
▼ 12 pts below national avg 83.1 · [object Object]
Industry payments
$124.69
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

WINIFRED MAK, MD reported a CMS MIPS final score of 71.5366/100 — below the 83.1 national average — and filed 24 Medicare Part D claims in 2023.

71.5366/100
MIPS score · -12 vs avg
24
Part D claims, 2023
54%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

WINIFRED MAK, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

72 9th percentile higher than 9% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

WINIFRED MAK, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about WINIFRED MAK, MD?

Below national average

NPI registry status

Active

Issued 07/03/2008

NPI 1912160680

Primary specialty

Reproductive Endocrinology Physician

Niche

1,413 US NPIs in this specialty

Medicare Part D claims

24 77% vs specialty avg

2023 prescription claims

Specialty avg: 104

MIPS final score

71.5366/100 11.563399999999987% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Pennsylvania

How Reproductive Endocrinology Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Reproductive Endocrinology Physician share within Pennsylvania

1. Reproductive Endocrinology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Reproductive Endocrinology Physician share within Pennsylvania

Medicare quality performance — MIPS

WINIFRED MAK, MD's 2023 MIPS final score plotted against the Reproductive Endocrinology Physician national average

Below national average
MIPS Final Score
71.5366/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Reproductive Endocrinology Physician) — 71.5366/100 vs national avg 83.1

0%100%National avg83%71.5%
MIPS final score (Reproductive Endocrinology Physician) — 71.5366/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

WINIFRED MAK, MD appears in the CMS NPPES registry as a Reproductive Endocrinology Physician provider holding MD credentials at 3400 SPRUCE ST, PHILADELPHIA, PA, 19104, with a listed phone of (215) 662-2459. NPI 1912160680 was issued on 07/03/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MAK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 24 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $483 in drug spend, split 46% brand-name and 54% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 71.5366/100 for the 2023 performance year (Quality 64.8573, Cost 69.5505), compared with the national average of 83.1.

Reproductive Endocrinology Physician is a narrow specialty nationwide, with 1,413 enrolled providers across 48 states and an average of 104 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3400 SPRUCE ST
PHILADELPHIA, PA 19104

Provider Details

NPI 1912160680
Specialty Reproductive Endocrinology Physician
Credentials MD
Gender Female
NPI Issued 07/03/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

71.5366
Final Score
Avg: 83.1
64.8573
Quality
69.5505
Cost

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for WINIFRED MAK, MD. Source: openpaymentsdata.cms.gov.

Total received

$125

Largest payer

Ferring Pharmaceuticals Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to WINIFRED MAK, MD. To verify WINIFRED MAK, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

WINIFRED MAK, MD — brand share 46.0%
Specialty average (est.)

46% brand-name claims vs 54% generic, on 24 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

24
Total Claims
$483
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
34
Total Day Supply
1,000
Brand vs Generic
46% brand / 54% generic
Brand Drug Cost
$160
Generic Drug Cost
$323

Patient Demographics

Average Patient Age
38.3 years
Avg HCC Risk Score
1.16

Reproductive Endocrinology Physician Overview

How WINIFRED MAK, MD fits within the Reproductive Endocrinology Physician landscape nationally.

1,413
Reproductive Endocrinology Physician Providers in US
48
States with Reproductive Endocrinology Physician
104
Avg Claims per Provider

WINIFRED MAK, MD's 24 claims are below the specialty average of 104.

Nearby Reproductive Endocrinology Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as MAK.

Compare Reproductive Endocrinology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is WINIFRED MAK, MD's specialty?
WINIFRED MAK, MD specializes in Reproductive Endocrinology Physician and practices in PHILADELPHIA, Pennsylvania. Credentials: MD.
How much does WINIFRED MAK, MD prescribe under Medicare Part D?
In 2023, WINIFRED MAK, MD wrote 24 Medicare Part D claims totaling $483 in drug costs for N/A beneficiaries.
What is WINIFRED MAK, MD's Medicare quality score?
WINIFRED MAK, MD has a CMS MIPS Final Score of 71.5366/100 (Quality: 64.8573, Cost: 69.5505). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is WINIFRED MAK, MD located?
WINIFRED MAK, MD is located at 3400 SPRUCE ST, PHILADELPHIA, PA, 19104. Phone: (215) 662-2459.
What is WINIFRED MAK, MD's NPI number?
WINIFRED MAK, MD's National Provider Identifier (NPI) is 1912160680, issued on 07/03/2008.
Does WINIFRED MAK, MD prescribe more brand-name or generic drugs?
WINIFRED MAK, MD's prescribing is 46% brand-name and 54% generic drugs by claim count, with $160 in brand drug costs.
How many Reproductive Endocrinology Physician providers are there in the US?
There are 1,413 Reproductive Endocrinology Physician providers across 48 states in the US. The average Reproductive Endocrinology Physician provider writes 104 Medicare Part D claims per year.
Does WINIFRED MAK, MD accept Medicare?
WINIFRED MAK, MD appears in CMS Medicare data with 24 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify WINIFRED MAK, MD's credentials?
WINIFRED MAK, MD's NPI is 1912160680 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology